Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R, 1999. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial. Lancet 353 :1463–1468.

Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R, 1999. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial. Lancet 353: 1463–1468.)| false
• Search Google Scholar
• Export Citation

Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kogozi A, Nakanjako D, Wafula W, Quick R, 2004. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364 :1428–1434.

Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kogozi A, Nakanjako D, Wafula W, Quick R, 2004. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364: 1428–1434.)| false
• Search Google Scholar
• Export Citation

Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P, 2006. Effect of cotrimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367 :1256–1261.

Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P, 2006. Effect of cotrimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367: 1256–1261.)| false
• Search Google Scholar
• Export Citation

Gill CJ, Sabin LL, Tham J, Hamer DH, 2004. Reconsidering cotrimoxazole prophylaxis for HIV-exposed African infants. Bull World Health Organ 82 :1–7.

Gill CJ, Sabin LL, Tham J, Hamer DH, 2004. Reconsidering cotrimoxazole prophylaxis for HIV-exposed African infants. Bull World Health Organ 82: 1–7.)| false
• Search Google Scholar
• Export Citation

Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L, 2008. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 79 :320–330.

Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L, 2008. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 79: 320–330.)| false
• Search Google Scholar
• Export Citation

Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH, 2008. Effect of presumptive cotrimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology, and antibiotic resistance among Zambian infants. Bull World Health Organ (in press).

Ministry of Health, 2006. National Guidelines for Diagnosis, Treatment & Prevention of Malaria for Health Workers. Republic of Kenya, Nairobi: Ministry of Health.

Montanari MP, Cochetti I, Mingoia M, Varaldo PE, 2003. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 47 :2236–2241.

Montanari MP, Cochetti I, Mingoia M, Varaldo PE, 2003. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 47: 2236–2241.)| false
• Search Google Scholar
• Export Citation

World Health Organization, 2005. Technical Updates on the Integrated Management of Childhood Illness (IMCI). Evidence and Recommendations for Further Adaptations. Geneva, Switzerland: World Health Organization.

Ministry of Health, 2007. Kenya Integrated Management of Childhood Illness Guidelines, 2007. Nairobi, Kenya: Ministry of Health.

Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B, Pakistan Cotrimoxazole Study Group, 1998. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 352 :270–274.

Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B, Pakistan Cotrimoxazole Study Group, 1998. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 352: 270–274.)| false
• Search Google Scholar
• Export Citation